GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Origin Therapeutics Holdings Inc (XCNQ:ORIG) » Definitions » Research & Development

Origin Therapeutics Holdings (XCNQ:ORIG) Research & Development : C$0.00 Mil (TTM As of Jun. 2023)


View and export this data going back to 2022. Start your Free Trial

What is Origin Therapeutics Holdings Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. Origin Therapeutics Holdings's Research & Development for the three months ended in Jun. 2023 was C$0.00 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Jun. 2023 was C$0.00 Mil.


Origin Therapeutics Holdings Research & Development Historical Data

The historical data trend for Origin Therapeutics Holdings's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Origin Therapeutics Holdings Research & Development Chart

Origin Therapeutics Holdings Annual Data
Trend Sep21 Sep22
Research & Development
- -

Origin Therapeutics Holdings Quarterly Data
Mar21 Jun21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23
Research & Development Get a 7-Day Free Trial Premium Member Only - - - - -

Origin Therapeutics Holdings Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Jun. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was C$0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Origin Therapeutics Holdings  (XCNQ:ORIG) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.


Origin Therapeutics Holdings Research & Development Related Terms

Thank you for viewing the detailed overview of Origin Therapeutics Holdings's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.


Origin Therapeutics Holdings Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
505 Burrard Street, Suite 1570, Vancouver, BC, CAN, V7X 1M5
Origin Therapeutics Holdings Inc is an investment company focusing on investments in the psychedelic industry.

Origin Therapeutics Holdings Headlines

From GuruFocus

Ocean Rig: More Upside On Strong 2Q14 Results

By Faisal Humayun Faisal Humayun 08-18-2014

5 Energy Stocks in Gurus' Portfolios

By Tiziano Frateschi Tiziano Frateschi 06-01-2018

Third Avenue Value Fund 3rd Quarter Letter

By Holly LaFon Holly LaFon 11-01-2018

Buy Ocean Rig Before Quarterly Results

By Faisal Humayun Faisal Humayun 02-09-2015

Transocean Ltd. Closes the Acquisition of Ocean Rig UDW Inc.

By Marketwired Marketwired 12-05-2018

Ocean Rig UDW Inc Joins the Russell 3000® Index

By Marketwired Marketwired 06-26-2018